News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Mrinal M. Patnaik: Divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Mrinal M. Patnaik/mayoclinic.org
Jan 27, 2025, 08:10

Mrinal M. Patnaik: Divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response

Mrinal M. Patnaik, Physician Scientist, Department of Internal Medicine at Mayo Clinic, Minnesota, shared a recent article by him and colleagues on X:

“Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response.

Why does DNMT3A CH increase mortality in the context of COVID-19 and VEXAS multiomics?”

“Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response“

Authors: Wazim Mohammed Ismail, Jenna A. Fernandez, Moritz Binder, Terra L. Lasho, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Liguo Wang, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Seul Kee Byeon, Susan M. Schwager, Jonathan J. Harrington, Melissa R. Snyder, Keith D. Robertson, Akhilesh Pandey, Eric D. Wieben, Nicholas Chia, Alexandre Gaspar-Maia and Mrinal M. Patnaik

Mrinal M. Patnaik

More posts featuring Mrinal M. Patnaik.

Akhilesh Pandey Alexandre Gaspar-Maia cancer COVID19 Eric D. Wieben Hematopoiesis inflammatory response Jenna A. Fernandez Minsuk Kim Moritz Binder Mrinal M Patnaik Nicholas Chia OncoDaily Oncology Terra L Lasho Vexas Wazim Mohammed Ismail
Special Coverage
Radiotherapy
Mar 3, 2025, 06:56
Radiotherapy for Bladder Cancer: Types, Success Rate, Side Effects And More
Positive
Mar 3, 2025, 06:21
THON 2025 Breaks Records: $17.7 Million Raised to Fight Childhood Cancer
Celebrities
Mar 2, 2025, 19:27
Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer
Insight
Mar 2, 2025, 14:36
Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab
Blog
Mar 2, 2025, 14:21
Chadi Nabhan: Debating Smoldering Myeloma on Healthcare Unfiltered
Science
Mar 2, 2025, 13:57
Mohammad Jad Moussa: Nivolumab plus ipilimumab in metastatic variant histology renal cell carcinoma
Blog
Mar 2, 2025, 13:50
Niyati Shah: Empowering Patients through Advocacy
Blog
Mar 2, 2025, 13:37
Cervical Cancer is Preventable: Education is Key - Medicaid Cancer Foundation
Career
Mar 2, 2025, 13:31
Irbaz Riaz: Honored to be named a Gerstner Scholar in AI Translation at Mayo Clinic
Science
Mar 2, 2025, 13:26
The ALEXANDRA/IMpassion030 trial on Adjuvant Atezolizumab for Early TNBC by Michail Ignatiadis et al.
Blog
Mar 2, 2025, 13:10
Monica Bertagnolli: All who pursue a career in biomedical research care deeply about the ultimate goals of the work
Science
Mar 2, 2025, 13:01
Hagop Youssoufian: Encelimab with or without dostarlimab in advanced/metastatic solid tumors